Thomson Reuters Corporation vs Takeda Pharmaceutical Company Limited
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
Thomson Reuters Corporation
$54.5B
์์ #268
Takeda Pharmaceutical Company Limited
$56.7B
์์ #263
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- Thomson Reuters Corporation์ด(๊ฐ) 2021๋ ๊น์ง Takeda Pharmaceutical Company Limited์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Takeda Pharmaceutical Company Limited์ด(๊ฐ) 2026๋ ๊น์ง Thomson Reuters Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | Thomson Reuters Corporation | Takeda Pharmaceutical Company Limited | ์ ๋ |
|---|---|---|---|
| 2026 | $54.5B | $56.7B | Takeda Pharmaceutical Company Limited |
| 2025 | $56.0B | $50.3B | Thomson Reuters Corporation |
| 2024 | $70.3B | $41.6B | Thomson Reuters Corporation |
| 2023 | $58.3B | $38.6B | Thomson Reuters Corporation |
| 2022 | $45.8B | $37.6B | Thomson Reuters Corporation |
| 2021 | $44.1B | $27.3B | Thomson Reuters Corporation |
| 2020 | $29.9B | $31.2B | Takeda Pharmaceutical Company Limited |
| 2019 | $26.1B | $34.2B | Takeda Pharmaceutical Company Limited |
| 2018 | $18.1B | $28.0B | Takeda Pharmaceutical Company Limited |
| 2017 | $13.8B | $46.8B | Takeda Pharmaceutical Company Limited |
| 2016 | $14.4B | $34.2B | Takeda Pharmaceutical Company Limited |
| 2015 | $12.4B | $41.4B | Takeda Pharmaceutical Company Limited |
| 2014 | $10.9B | $33.1B | Takeda Pharmaceutical Company Limited |
| 2013 | $9.0B | $30.8B | Takeda Pharmaceutical Company Limited |
| 2012 | $6.2B | $23.7B | Takeda Pharmaceutical Company Limited |
| 2011 | $5.6B | $19.8B | Takeda Pharmaceutical Company Limited |
| 2010 | $7.4B | $22.3B | Takeda Pharmaceutical Company Limited |
| 2009 | $6.6B | $20.5B | Takeda Pharmaceutical Company Limited |
| 2008 | $6.7B | $23.7B | Takeda Pharmaceutical Company Limited |